Ifg Advisory, LLC Seagen Inc. Transaction History

Ifg Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $66,453 - $75,007	347 Added 0.69%	50,900 $10.8 Million
Q2 2023 Jul 21, 2023	BUY	$187.64 - $206.25 $3.06 Million - $3.36 Million	16,283 Added 47.51%	50,553 $9.73 Million
Q1 2023 Apr 26, 2023	BUY	$127.59 - $203.08 $3.12 Million - $4.97 Million	24,475 Added 249.87%	34,270 $6.94 Million
Q4 2022 Jan 31, 2023	SELL	$117.37 - $139.17 $67,605 - $80,161	-576 Reduced 5.55%	9,795 $1.26 Million
Q3 2022 Oct 28, 2022	BUY	$135.27 - $180.11 $1.4 Million - $1.87 Million	10,371 New	10,371 $1.42 Million

Q1 2022 May 04, 2022	SELL	$119.61 - $157.85 $221,517 - $292,338	-1,852 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $8,696 - $11,642	-61 Reduced 3.19%	1,852 $286,000
Q2 2021 Jul 21, 2021	BUY	$135.08 - $161.1 $258,408 - $308,184	1,913 New	1,913 $302,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.